Treatment strategies for patients with colorectal carcinoma and synchronous liver metastases

Czech version

Authors: P. Ihnát; P. Ostruszka; P. Vávra; M. Peteja; P. Zonča
Authors‘ workplace: Chirurgická klinika Fakultní nemocnice Ostrava, Katedra chirurgických oborů Lékařské fakulty Ostravské univerzity, Ostrava
Published in: Rozhl. Chir., 2018, roč. 97, č. 10, s. 451-454.
Category: Review

Overview

Multimodal approach in the management of patients with colorectal carcinoma and synchronous liver metastases allows for the application of various combinations of treatment modalities (colorectal resection, liver resection, chemotherapy, radiotherapy). The primary-first approach and simultaneous resection represent traditional strategies used because the primary tumor is thought to be the main source of subsequent metastases as well as the source of symptoms associated with local tumor progression (obstruction, perforation, colorectal bleeding).

Poor long-term outcomes of traditional strategies have led to the proposal of reverse strategies (the liver-first approach and up-front hepatectomy approach). The idea behind reverse strategies is to give preference to liver resection over colorectal resection (prognosis of patients with stage IV colorectal cancer is determined mainly by the curability of liver metastases). According to available literature, reverse strategies are suitable mainly for patients with asymptomatic primary tumor.

Treatment strategy for each patient should be individualized depending on the patient’s performance status, comorbidities, and tumor stage. In this paper, the authors offer an up-to-date review of treatment strategies for patients with colorectal carcinoma and synchronous liver metastases focusing on available data of evidence-based medicine.

Key words:

liver first – primary first – colorectal carcinoma – liver metastases – reverse strategies

Sources

1. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007;16:3−5.

2. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of colorectal liver metastases from colorectal cancer. Ann Surg 2006;244:254−9.

3. Khan K, Wale A, Brown G, et al. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014;20:12391−06.

4. Tsai MS, Su YH, Ho MC, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007;14:786−94.

5. Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 2009;4:56−62.

6. Třeška V. Chirurgie jater pro metastázy kolorektálního karcinomu. Rozhl Chir 2018;97:149−55.

7. Jegatheeswaran S, Mason JM, Hancock HC, et al. The liver-first approach to the management of colorectal cancer with synchronou hepatic metastases: a systematic review. JAMA Surg 2013;148:385−91.

8. Lykoudis PM, O’Reilly, Nastos K, et al. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg 2014;101:605−12.

9. Broquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronnous colorectal liver metastases in 156 consecutive patients: classis, combined or revesed strategy? J Am Coll Surg 2010;210:934−41.

10. Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surgery 2011;3:183−96.

11. Mentha G, Roth AD, Terraz S, et al. Liver first approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008;25:430−5.

12. De Rosa A, Gomez D, Brooks A, et al. „Liver-first“ approach for synchronous colorectal liver metastases: is this a justifiable approach? J Hepatobiliary Pancreat Sci 2013;20:263−70.

13. Tsoulfas G, Pramateftakis MG. Management of rectal cancer and liver metastatic disease: which comes first? Int J Surg Oncol 2012;2012:196908.

14. Andreas A, Toso C, Adam R, et al. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012;256:772−8.

15. Fahy BN, Fischer CP. Synchronous resection of colorectal primary and hepatic metastasis. J Gastrointest Oncol 2012;3:48−58.

16. De Haas RJ, Adam R, Wicherts DA, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 2010;97:1279−89.

17. Třeška V, Skalický T, Ferda J, et al. Resekce jater pro metastázy kolorektálního karcinomu – současnost a perspektivy. Rozhl Chir 2014;93:568−71.

18. Adam R, Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. The Oncologist 2012;17:1225−39.

19. Pudil J, Batko S, Menclová K, et al. „Liver first“ přístup v léčbě synchronních jaterních metastáz kolorektálního karcinomu. Rozhl Chir 2015;94:522−5.

20. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure. J Clin Oncol 2006;24:393-5.

21. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009;27:3379−84.

22. Sheer MGW, Sloots CEJ, van der Wilt GJ, et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Annals of Oncology 2008;19:1829–35.

23. Grundmann RT, Hermanek P, Merkel S, et al. Diagnosis and treatment of colorectal liver metastases – workflow. Zentralbl Chir 2008;133:267−84.

24. Straka M, Migrová M, Soumarová R, et al. Reverzní prístup k synchrónnym pečeňovým metastázam kolorektálního karcinómu. Absolvovanie liečebného protokolu, strednodobé (trojročné) prežívanie a vzorec progresie ochorenia u 32 pacientov. Rozhl Chir 2016;95:208−6.

25. Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010;107:335−42.

26. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371:1007−16.

27. Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 2008;34:609–14.

28. Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274−86.

29. Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009;16:137−44.

30. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1−7.

31. Lehmann K, Rickenbacher A, Weber A, et al. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012;255:237−47.

32. Zhu D, Zhong Y, Wei Y, et al. Effect of neoadjuvant chemohterapy in patients with resectable colorectal liver metastases. PLoS One 2014;9:e86543.

33. Nanji S, Cleary S, Ryan P, et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol 2013;20:295−304.

34. Mentha G, Terraz S, Morel P, et al. Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 2009;96:95−103.

35. Tanaka K, Takakura H, Takeda K, et al. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg 2009;250:935–42.

36. Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases? Is there a possibility of cure? J Clin Oncol 2009;27:1829−35.

37. Stein A, Schmoll HJ. Systemic treatment of liver metastases from colorectal cancer. Ther Adv Med Oncol 2013;5:193−203.

38. Straka M, Skrovina M, Soumarova R, et al. Up front hepatectomy for metastatic rectal carcinoma – reversed, liver first approach. Early experience with 15 patients. Neoplasma 2014;61:447−52.

39. Lubezky N, Geva R, Shmueli E, et al. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg 2009;33:1028−34.

40. Kelly ME, Spolverato G, Le GN, et al. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined and liver-first surgical strategies. J Surg Oncol 2015;111:341−51.